Nuvation Bio Inc. Class A Common Stock vs Powell Industries — how do they compare? Nuvation Bio Inc. Class A Common Stock trades at $5.01 (market cap $1.74B), while Powell Industries trades at $195.01 (market cap $6.89B). The key difference: Powell Industries is far larger — about 4× Nuvation Bio Inc. Class A Common Stock's market cap, and Powell Industries pays a 0.19% dividend while Nuvation Bio Inc. Class A Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Nuvation Bio Inc. Class A Common Stock for 1 Days and Powell Industries for 5 Days on average.
| NUVB | POWL | |
|---|---|---|
Market Cap | $1.74B | $6.89B |
Volume | 9,289,619 | 728,725 |
Sector | Health | Industrials |
52-Week High | $9.54 | $322.05 |
52-Week Low | $3.41 | $94.02 |
Typical Hold Time | 1 Days | 5 Days |
Enterprise Value | $1.33B | $6.26B |
Dividend Yield | — | 0.19% |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Nuvation Bio Inc. is a biopharmaceutical company focused on oncology, developing novel cancer treatments including taletrectinib (marketed as IBTROZI), a ROS1 inhibitor, and safusidenib, a brain-penetrant IDH1 inhibitor.
Read more on NUVB →Powell Industries designs and manufactures electrical equipment and engineered solutions for power distribution and control. Its products are used across energy, utility, industrial, and commercial infrastructure.
Read more on POWL →